Our analysis of adult progenitor cells in the bone marrow and fetal livers indicated a substantial increase in the B1a B progenitors in the bone marrow, but not in the fetal or new born liver.
Although IFNγ levels per se were not affected, IFNγ target genes were significantly down-regulated in rAd.A20, as opposed to rAd.βgal treated livers, indicating a disruption in IFNγ signaling.
Surprisingly, both were decreased in MnSOD-deficient HepG2 hepatoma cells as well as in MnSOD absent mouse livers, indicating a dysregulation of β-catenin on expression rather than on stability.
This showed that some cancer cells still remained in the liver, indicating a need to remain vigilant and consider further treatment.
A comparison of the locations of the sites of breakage in duplex DNA generated by the topoisomerases from wheat germ and rat liver indicates a number of common sites, although the patterns of breakage are not identical.
Imaging was done every 2 3 weeks to monitor whether luciferase expression was observed in locations outside of the liver, indicating a possible luciferase-positive metastasis.
Mice that were injected with pLiLucB were imaged the next day to confirm high levels of luciferase expression in the liver, indicating a successful hydrodynamic injection.
Significant changes to creatine and phosphocreatine levels in liver indicated a perturbation to energy metabolism.
However, these changes were not as evident as those observed in the liver, indicating a milder mitochondrial phenotype.
Activation of the oval cell compartment, as seen in the Ncu-g1 gt/gt liver, indicates a suppressed hepatocyte proliferation at 6 months of age.
